Contineum Therapeutics (CTNM) Other Working Capital Changes (2023 - 2026)
Contineum Therapeutics (CTNM) posted quarterly Other Working Capital Changes of -$380000.0 for Q2 2026, down 50.79% year-over-year from -$772258.1 in Q2 2025, and up 70.68% quarter-over-quarter from -$1.3 million in Q1 2026.
Powered by 
Analysis
Contineum Therapeutics (CTNM) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$380000.0 for Q2 2026.
- In Q2 2026, Other Working Capital Changes fell 50.79% year-over-year to -$380000.0; the TTM figure through Jun 2026 stood at -$2.4 million (down 418.8% YoY), while the FY2025 annual figure was -$1.3 million, down 2010.61% from the prior year.
- Other Working Capital Changes for Q2 2026 stood at -$380000.0, up from -$1.3 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $2.5 million in Q4 2025, with the low at -$713000.0 in Q1 2024.
- The 4-year median for Other Working Capital Changes is -$11000.0 (2023), against an average of $342214.3.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes jumped 105.12% in 2024, then slumped 2241.67% in 2025.
- Contineum Therapeutics' Other Working Capital Changes stood at -$549000.0 in 2023, then jumped by 105.1% to $28000.0 in 2024, then tumbled by 1867.86% to -$495000.0 in 2025, then advanced by 23.23% to -$380000.0 in 2026.
- Business Quant data shows CTNM's Other Working Capital Changes at -$380000.0 in Q2 2026, -$1.3 million in Q1 2026, and -$495000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Contineum Therapeutics | 628.71 Mn | 628.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.29 Mn |
| Jun 30, 2026 | -3.29 Mn |
| Mar 31, 2026 | 1.62 Mn |
| Mar 31, 2026 | 1.62 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | -252,000.00 |
| Jun 30, 2025 | -252,000.00 |
| Mar 31, 2025 | -257,000.00 |
| Mar 31, 2025 | -257,000.00 |
| Dec 31, 2024 | 394,000.00 |
| Dec 31, 2024 | 394,000.00 |
| Sep 30, 2024 | -435,000.00 |
| Sep 30, 2024 | -435,000.00 |
| Jun 30, 2024 | -133,000.00 |
| Jun 30, 2024 | -133,000.00 |
| Mar 31, 2024 | -713,000.00 |
| Mar 31, 2024 | -713,000.00 |